サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529625

インスリンデリバリーデバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント別予測、2024年～2030年

Insulin Delivery Devices Market Size, Share & Trends Analysis Report By Product (Reusable Insulin Pens, Disposable Insulin Pens), By End Use (Hospitals & Clinics, Homecare), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
インスリンデリバリーデバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年07月02日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

インスリンデリバリーデバイス市場の成長と動向：

インスリンデリバリーデバイスの世界市場規模は、2030年には280億6,000万米ドルと推定され、2024年から2030年にかけてCAGR 7.89%で成長すると予測されます。

主に若年層における肥満、座りがちなライフスタイル、不健康な食習慣が糖尿病の発生につながります。さらに、糖尿病老年人口の増加もこの分野の成長を支える要因のひとつです。国連経済社会局によると、2015年には約9億100万人が60歳以上であり、この数は2030年までに14億人に増加すると予測されています。このように、高齢者人口の増加は、インスリンデリバリーデバイスの需要を押し上げると予想されています。

技術革新と進歩は、この分野では継続的な動向です。先進的なインスリンデリバリーデバイスに対する高い需要が、最近発売された革新的なペン型デバイスや携帯型ポンプの採用を後押ししており、これが市場成長を押し上げると推定されます。また、米国やドイツのような先進国を中心に、これらのデバイスに対する有利な償還政策が、調査期間中の市場成長を促進すると予測されています。しかし、インスリンデリバリーデバイスの承認を規制する厳しい規制要件と、糖尿病ケア管理におけるインスリンアナログの高コストは、この業界の成長を抑制する主な要因です。

同市場の著名な競合企業は、製品ポートフォリオの拡大や製造能力の強化を図るため、買収、資金調達、製品開発など、さまざまな取り組みを行っています。例えば、2021年10月、Eli LillyはCiplaと提携し、同社のインスリン製剤（HumalogとTrulicity）をインドで販売します。さらに2021年6月、同社は市場での存在感を強化するため、Protomer Technologies社を買収しました。さらに、Novo Nordisk社はBiocorp社と提携し、同社のペン型インスリン注射器用のBluetooth対応スマートアドオンデバイスを開発しました。

インスリンデリバリーデバイス市場レポートハイライト

  • インスリンペンセグメントは、2021年の同市場で最大の収益を生み出すカテゴリーでした。ペンは自己完結型のカートリッジを備えており、取り扱いが容易でインスリン注入時の痛みが少ないです。このようなペン型デバイスは他の製品よりも優れているため、人気が高まっており、同市場における同分野の最高シェアに寄与する重要な要因となっています。
  • 在宅ケアセグメントは、セルフケア糖尿病管理デバイスの採用が増加し、患者にとって簡便で使いやすい製品設計が利用可能になったことから、最も急成長しているセグメントと推定されます。
  • 北米は主要な地域分野であり、2021年に最大の売上シェアを占めました。これは主に、この分野における有利な償還シナリオによるものです。また、この地域には大手メーカーが存在し、市場の成長を支えています。
  • アジア太平洋地域では、予測期間中に市場が急成長すると予測されています。中国やインドなどの国々で糖尿病の有病率が高いことが、この地域の市場拡大に寄与する主な要因です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 インスリンデリバリーデバイス市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • インスリンデリバリーデバイス市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 インスリンデリバリーデバイス市場：製品の推定・動向分析

  • セグメントダッシュボード
  • 世界のインスリンデリバリーデバイス市場：製品の変動分析
  • 世界のインスリンデリバリーデバイス市場規模と動向分析：製品別、2018～2030年
  • インスリンペン
  • インスリンポンプ
  • インスリンペンニードル
  • インスリンシリンジ
  • その他

第5章 インスリンデリバリーデバイス市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • 世界のインスリンデリバリーデバイス市場：用途の変動分析
  • 世界のインスリンデリバリーデバイス市場規模と動向分析：最終用途別、2018～2030年
  • 病院・クリニック
  • 在宅ケア
  • その他

第6章 インスリンデリバリーデバイス市場：地域の推定・動向分析、製品別、最終用途別

  • 地域の市場シェア分析、2023年・2030年
  • 地域の市場ダッシュボード
  • 世界の地域の市場スナップショット
  • 市場規模と予測・動向分析、2018年～2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 主要企業の市場シェア分析、2023年
  • 企業ポジション分析
  • 企業分類（新興企業、イノベーター、リーダー）
  • 企業プロファイル
    • Novo Nordisk A/S
    • Sanofi
    • Eli Lilly and Company
    • Ypsomed AG
    • Medtronic
    • Insulet Corporation
    • B. Braun SE
    • Owen Mumford Ltd.
    • Tandem Diabetes Care, Inc.
    • BD
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America insulin delivery devices market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 5 North America insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 7 U.S insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 8 Canada insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 9 Canada insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Mexico insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 11 Mexico insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe insulin delivery devices market, By country, 2018 - 2030 (USD Million)
  • Table 13 Europe insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 14 Europe insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 15 UK insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 16 UK insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 18 Germany insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 19 France insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 20 France insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 22 Italy insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Denmark insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 24 Denmark insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 25 Sweden insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 26 Sweden insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 27 Norway insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 28 Norway insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific insulin delivery devices market, By country, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Japan insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 33 Japan insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 34 China insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 35 China insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 36 India insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 37 India insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Australia insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 39 Australia insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 40 South Korea insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 41 South Korea insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 43 Thailand insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 44 Latin America insulin delivery devices market, By Country, 2018 - 2030 (USD Million)
  • Table 45 Latin America insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 46 Latin America insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 47 Brazil insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 48 Brazil insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 49 Argentina insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 50 Argentina insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa insulin delivery devices market, By country, 2018 - 2030 (USD Million)
  • Table 52 Middle East & Africa insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 South Africa insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 55 South Africa insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 58 UAE insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 59 UAE insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait insulin delivery devices market, By product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait insulin delivery devices market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Insulin delivery devices market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Insulin delivery devices market driver impact
  • Fig. 19 Insulin delivery devices market restraint impact
  • Fig. 20 Insulin delivery devices market: Product movement analysis
  • Fig. 21 Insulin delivery devices market: Product outlook and key takeaways
  • Fig. 22 Insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 23 Reusable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 24 Disposable insulin pens market estimates and forecast, 2018 - 2030
  • Fig. 25 Insulin pumps market estimates and forecast, 2018 - 2030
  • Fig. 26 Patch pumps market estimates and forecast, 2018 - 2030
  • Fig. 27 Tethered pumps market estimates and forecast, 2018 - 2030
  • Fig. 28 Insulin pen needles market estimates and forecast, 2018 - 2030
  • Fig. 29 Standard pen needles market estimates and forecast, 2018 - 2030
  • Fig. 30 Safety pen needles market estimates and forecast, 2018 - 2030
  • Fig. 31 Insulin syringes market estimates and forecast, 2018 - 2030
  • Fig. 32 Other products market estimates and forecast, 2018 - 2030
  • Fig. 33 Insulin delivery devices market: End use movement analysis
  • Fig. 34 Insulin delivery devices market: End use outlook and key takeaways
  • Fig. 35 Hospitals and clinics market estimates and forecast, 2018 - 2030
  • Fig. 36 Homecare market estimates and forecast, 2018 - 2030
  • Fig. 37 Others end users market estimates and forecast, 2018 - 2030
  • Fig. 38 Global insulin delivery devices market: Regional movement analysis
  • Fig. 39 Global insulin delivery devices market: Regional outlook and key takeaways
  • Fig. 40 North America
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 U.S.
  • Fig. 43 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 44 Canada
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 46 Mexico
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 48 Europe
  • Fig. 49 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 50 UK
  • Fig. 51 UK market estimates and forecasts, 2018 - 2030
  • Fig. 52 Germany
  • Fig. 53 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 54 France
  • Fig. 55 France market estimates and forecasts, 2018 - 2030
  • Fig. 56 Italy
  • Fig. 57 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 58 Spain
  • Fig. 59 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 60 Denmark
  • Fig. 61 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 62 Sweden
  • Fig. 63 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 64 Norway
  • Fig. 65 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 66 Asia Pacific
  • Fig. 67 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 68 China
  • Fig. 69 China market estimates and forecasts, 2018 - 2030
  • Fig. 70 Japan
  • Fig. 71 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 72 India
  • Fig. 73 India market estimates and forecasts, 2018 - 2030
  • Fig. 74 Thailand
  • Fig. 75 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 76 South Korea
  • Fig. 77 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 78 Australia
  • Fig. 79 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 80 Latin America
  • Fig. 81 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 82 Brazil
  • Fig. 83 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 84 Mexico
  • Fig. 85 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 86 Argentina
  • Fig. 87 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 88 Middle East and Africa
  • Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 90 South Africa
  • Fig. 91 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 92 Saudi Arabia
  • Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 94 UAE
  • Fig. 95 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 96 Kuwait
  • Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 98 Market share of key market players- Insulin delivery devices market
目次
Product Code: GVR-1-68038-991-3

Insulin Delivery Devices Market Growth & Trends:

The global insulin delivery devices market size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% from 2024 to 2030. Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, the growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. The high demand for advanced insulin delivery devices is supporting the adoption of recently launched innovative pen devices and portable pumps, which is estimated to boost the market growth. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices and the high cost of insulin analogs in diabetes care management are major factors restraining the growth of this industry.

The market's prominent competitors are taking different initiatives such as acquisition, funding, and product development to expand their product portfolio and enhance their manufacturing capacity. For instance, in October 2021, Eli Lilly partnered with Cipla, to market its Insulin products (Humalog and Trulicity) in India. Additionally, In June 2021, the company acquired Protomer Technologies, to strengthen its market presence. Further, Novo Nordisk, joined hands with Biocorp to develop a Bluetooth-enabled smart add-on device for their pen insulin injector.

Insulin Delivery Devices Market Report Highlights:

  • The insulin pens segment was the largest revenue-generating category of this market in 2021. The pen is equipped with self-contained cartridges and offers ease in handling and less pain while injecting insulin. The advantages of these pen devices over other products are resulting in their growing popularity, thus serving as a vital factor in contributing to the sectorb s highest share in this market
  • The home care segment is estimated to be the fastest-growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients
  • North America is the leading regional sector and accounted for the largest revenue share in 2021 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting market growth
  • In Asia Pacific, the market is anticipated to grow fast during the forecast period. The high prevalence rate of diabetes in countries, such as China and India, is a major factor contributing to market expansion in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Insulin Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rise in the prevalence of diabetes globally
      • 3.2.1.2. Increasing geriatric population
      • 3.2.1.3. Favorable government reimbursement scenario
      • 3.2.1.4. Increasing awareness about diabetes preventive care
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulatory framework
      • 3.2.2.2. High cost of devices
  • 3.3. Insulin Delivery Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Insulin Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Insulin Delivery Devices Product Market Movement Analysis
  • 4.3. Global Insulin Delivery Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Insulin Pens
    • 4.4.1. Insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Reusable Insulin Pens
      • 4.4.2.1. Reusable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Disposable Insulin Pens
      • 4.4.3.1. Disposable insulin pens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Insulin Pumps
    • 4.5.1. Insulin pumps market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Patch Pumps
      • 4.5.2.1. Patch pumps market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Tethered Pumps
      • 4.5.3.1. Tethered pumps market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Insulin Pen Needles
    • 4.6.1. Insulin pen needles market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Standard Pen Needles
      • 4.6.2.1. Standard pen needles market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Safety Pen Needles
      • 4.6.3.1. Safety pen needles market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Insulin Syringes
  • 4.8. Other Products

Chapter 5. Insulin Delivery Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Insulin Delivery Devices End Use Market Movement Analysis
  • 5.3. Global Insulin Delivery Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals & Clinics
    • 5.4.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Homecare
    • 5.5.1. Homecare market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Other End User
    • 5.6.1. Other End Users market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Insulin Delivery Devices Market: Regional Estimates & Trend Analysis By Product, End Use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement structure
      • 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement structure
      • 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement structure
      • 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement structure
      • 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement structure
      • 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement structure
      • 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Competitive scenario
      • 6.6.4.3. Regulatory framework
      • 6.6.4.4. Reimbursement structure
      • 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Competitive scenario
      • 6.6.5.3. Regulatory framework
      • 6.6.5.4. Reimbursement structure
      • 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Competitive scenario
      • 6.6.6.3. Regulatory framework
      • 6.6.6.4. Reimbursement structure
      • 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Competitive scenario
      • 6.6.7.3. Regulatory framework
      • 6.6.7.4. Reimbursement structure
      • 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Competitive scenario
      • 6.6.8.3. Regulatory framework
      • 6.6.8.4. Reimbursement structure
      • 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement structure
      • 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement structure
      • 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement structure
      • 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement structure
      • 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement structure
      • 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement structure
      • 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement structure
      • 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement structure
      • 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement structure
      • 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement structure
      • 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement structure
      • 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Competitive scenario
      • 6.9.4.3. Regulatory framework
      • 6.9.4.4. Reimbursement structure
      • 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share analysis, 2023
  • 7.4. Company Position Analysis
  • 7.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 7.6. Company Profiles
    • 7.6.1. Novo Nordisk A/S
      • 7.6.1.1. Company overview
      • 7.6.1.2. Financial performance
      • 7.6.1.3. Product benchmarking
      • 7.6.1.4. Strategic initiatives
    • 7.6.2. Sanofi
      • 7.6.2.1. Company overview
      • 7.6.2.2. Financial performance
      • 7.6.2.3. Product benchmarking
      • 7.6.2.4. Strategic initiatives
    • 7.6.3. Eli Lilly and Company
      • 7.6.3.1. Company overview
      • 7.6.3.2. Financial performance
      • 7.6.3.3. Product benchmarking
      • 7.6.3.4. Strategic initiatives
    • 7.6.4. Ypsomed AG
      • 7.6.4.1. Company overview
      • 7.6.4.2. Financial performance
      • 7.6.4.3. Product benchmarking
      • 7.6.4.4. Strategic initiatives
    • 7.6.5. Medtronic
      • 7.6.5.1. Company overview
      • 7.6.5.2. Financial performance
      • 7.6.5.3. Product benchmarking
      • 7.6.5.4. Strategic initiatives
    • 7.6.6. Insulet Corporation
      • 7.6.6.1. Company overview
      • 7.6.6.2. Financial performance
      • 7.6.6.3. Product benchmarking
      • 7.6.6.4. Strategic initiatives
    • 7.6.7. B. Braun SE
      • 7.6.7.1. Company overview
      • 7.6.7.2. Financial performance
      • 7.6.7.3. Product benchmarking
      • 7.6.7.4. Strategic initiatives
    • 7.6.8. Owen Mumford Ltd.
      • 7.6.8.1. Company overview
      • 7.6.8.2. Financial performance
      • 7.6.8.3. Product benchmarking
      • 7.6.8.4. Strategic initiatives
    • 7.6.9. Tandem Diabetes Care, Inc.
      • 7.6.9.1. Company overview
      • 7.6.9.2. Financial performance
      • 7.6.9.3. Product benchmarking
      • 7.6.9.4. Strategic initiatives
      • 7.6.9.5. Company overview
    • 7.6.10. BD
      • 7.6.10.1. Company overview
      • 7.6.10.2. Financial performance
      • 7.6.10.3. Product benchmarking
      • 7.6.10.4. Strategic initiatives
      • 7.6.10.5. Company overview